Healthcare Services Acquisitions in Canada

Healthcare Services M&A in Canada

Healthcare Services M&A in Canada covers recent acquisitions and investments across clinics, pharmacies, home‑care and digital health. Transactions range from large take‑privates to targeted tuck‑ins that expand clinical, operational and technology capabilities.

Deal themes include private‑equity and strategic platform activity (for example, GTCR LLC acquiring dentalcorp Holdings Ltd.), clinic and pharmacy roll‑ups by operators such as WELL Health Technologies Corp. and PharmaCorp Rx Inc., and capability deals that add digital health, RWE/HEOR and clinical decision‑support (for example, United BioSource LLC (UBC) acquiring Evidinno Outcomes Research Inc. and DoseMe acquiring Firstline). Geography is concentrated in Ontario and British Columbia with notable activity in Quebec and Manitoba.

What Stands Out

  • Private equity and strategic platforms are prominent buyers: examples include GTCR LLC, Frontline Healthcare Partners, SeaFort Capital and clinic consolidators like WELL Health Technologies Corp.
  • Digital and data capabilities are being acquired to extend clinical workflows: RWE/HEOR (United BioSource LLC (UBC) / Evidinno), clinical decision support and precision dosing (DoseMe / Firstline), patient engagement platforms (FluidAI Medical / Emmetros), and patient‑flow software (VitalHub Corp. / Novari Health Inc.).
  • Traditional service roll‑ups continue (clinics, pharmacies, home care and specialty services): examples include clinic buys in British Columbia, a pharmacy purchase in Western Canada by PharmaCorp Rx Inc., and regional expansion by Mable Health Inc. into Manitoba.
  • Geographic focus: Ontario and British Columbia appear most often, with transactions also in Quebec and Manitoba.
  • Buyer
    ClinActiv Holdings, ClinActiv Holdings affiliate
    Target
    Crescita Therapeutics
    Location
    Ontario, Canada
    Type
    Buyout

    Crescita Therapeutics entered into a definitive arrangement agreement to be acquired by ClinActiv Holdings in an all-cash deal valued at $0.80 per share (minimum $0.75), subject to customary working capital adjustments. The transaction is expected to close in Q2 2026 via a court-approved statutory plan of arrangement in Ontario, with Crescita’s shares to be delisted after completion.

  • Buyer
    BioSyent Inc.
    Target
    Oral Science Inc.
    Seller
    Shareholders of Oral Science (the “Sellers”)
    Location
    Quebec, Canada
    Type
    Buyout

    BioSyent Inc. (TSX Venture: RX) has closed its previously announced acquisition of Oral Science Inc. for an aggregate purchase price of $25.5 million. The deal was completed under a February 8, 2026 Share Purchase Agreement, with consideration paid via cash ($22.5 million, including additional working-capital adjustment) and BioSyent common shares, plus contingent earn-out and royalty payments.

  • Buyer
    iGan Partners
    Target
    Exact Imaging
    Location
    Ontario, Canada

    Exact Imaging, a developer of high-resolution micro-ultrasound for urologic imaging, announced the closing of a $10 million financing round led by iGan Partners. The proceeds will be used to accelerate global sales and adoption of its ExactVu prostate biopsy system.

  • Buyer
    Apollo-Managed Funds, Apollo Global Management
    Target
    The GoodLife Group
    Location
    Ontario, Canada

    Apollo-managed funds have acquired a minority investment in The GoodLife Group, Canada’s largest gym operator, to provide capital for its long-term growth strategy. The deal is subject to customary regulatory approvals and closing conditions, and GoodLife’s founder/Chairman David “Patch” Patchell-Evans and CEO Jeff van Haeren are expected to remain in their roles.

  • Buyer
    fdp Private Wealth Management, fdp Gestion privée
    Target
    MultiD
    Location
    Quebec, Canada
    Type
    Buyout

    fdp Private Wealth Management announced the immediate acquisition of a majority interest in MultiD, a Quebec-based medical billing and administrative solutions firm. The deal is intended to create a fully integrated medical-finance offering for physicians across Quebec while maintaining MultiD’s brand and service continuity.

  • Buyer
    GreenShield
    Target
    Kii Health's Canadian mental health services segment
    Seller
    Kii Health
    Location
    Ontario, Canada
    Type
    Buyout

    GreenShield has acquired Kii Health’s Canadian mental health services segment, including EFAP, Student Assistance Program (SAP), CBT Associates, and TAiCBT services, along with the MindBeacon digital therapy platform. The deal expands GreenShield Health’s mental health capabilities and grows its national footprint—particularly in Western Canada and Quebec—while integrating the acquired offerings into GreenShield+.

  • Buyer
    ATB Financial Private Equity arm (ATB PE), Prominent Canadian family office (name not specified)
    Target
    Corus Orthodontists Inc.
    Location
    Alberta, Canada

    Corus Orthodontists Inc. announced a C$20 million institutional equity investment led by ATB Financial’s private equity arm, with co-investment from a prominent Canadian family office. The funding is intended to support further clinic expansion across the U.S. and Canada and to provide progressive equity liquidity to Corus’ existing shareholders.

  • Buyer
    WELL Health Technologies Corp.
    Target
    E-Consult Canada LP, eight primary care clinics in Alberta (clinic business acquired via absorption model)
    Location
    Alberta, Canada
    Type
    Buyout

    WELL Health Technologies Corp. acquired a majority 61% ownership interest in E-Consult Canada LP for approximately CAD 33 million and completed the acquisition effective February 1, 2026. In addition, WELL acquired eight primary care clinics in Alberta (closing December 1, 2025), taking 100% ownership of the clinic business through its absorption model.

  • Buyer
    Elevate Farms Inc.
    Target
    Fieldless Farms Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    Elevate Farms Inc. acquired 100% of Fieldless Farms Inc., making Fieldless a wholly owned subsidiary of Elevate. The deal brings together Elevate’s controlled-environment agriculture (CEA) technology platform with Fieldless’s Cornwall, Ontario pesticide-free leafy greens operations, aiming to strengthen Canadian food sovereignty and enable global expansion.

  • Buyer
    Victoria Park Medispa
    Target
    PHI Medical Aesthetics
    Location
    Alberta, Canada
    Type
    Buyout

    Victoria Park Medispa, a Canadian medical aesthetics platform, has acquired PHI Medical Aesthetics as its first entry into Alberta and the western provinces. The transaction is positioned as the start of Victoria Park’s broader westward expansion strategy, adding PHI’s Calgary injectables-focused clinic to its growing national network.

  • Buyer
    GTCR LLC (funds affiliated with GTCR LLC), Aryeh Topco Holding Ltd., Aryeh Bidco Investment Ltd.
    Target
    dentalcorp Holdings Ltd.
    Seller
    Dentalcorp shareholders (including Graham Rosenberg, Nate Tchaplia, and certain partner dentists via rollover structures)
    Location
    Ontario, Canada
    Type
    Buyout

    Funds affiliated with GTCR LLC acquired 100% of dentalcorp Holdings Ltd. through a statutory plan of arrangement, paying C$11.00 per share in cash. The transaction valued dentalcorp at approximately C$2.2 billion on an equity basis and C$3.3 billion on an enterprise value basis, and resulted in the company being taken private.

  • Buyer
    United BioSource LLC (UBC)
    Target
    Evidinno Outcomes Research Inc.
    Location
    British Columbia, Canada
    Type
    Buyout

    United BioSource LLC (UBC) has acquired Vancouver-based Evidinno Outcomes Research Inc., adding real-world evidence (RWE), epidemiology, evidence synthesis and HEOR capabilities to UBC's evidence-generation platform. Evidinno will operate as a wholly owned subsidiary of UBC; Fairmount Partners served as exclusive financial advisor to Evidinno.

  • Buyer
    FluidAI Medical
    Target
    Emmetros Limited
    Location
    Ontario, Canada
    Type
    Buyout

    FluidAI Medical acquired Emmetros Limited, the developer of the SparxConnect patient engagement platform, to integrate its capabilities into FluidAI's Stream Inara offering. The deal strengthens FluidAI's RISE surgical recovery suite by expanding patient education, continuous engagement, and post-discharge monitoring to support earlier discharge and improved recovery outcomes.

  • Buyer
    GE HealthCare
    Target
    Intelerad
    Seller
    Hg Capital, TA Associates
    Location
    Canada
    Type
    Buyout

    GE HealthCare entered into an agreement to acquire Intelerad, a medical imaging software provider, for $2.3 billion in cash. The deal is intended to expand GE HealthCare’s cloud-first, AI-enabled enterprise imaging portfolio across outpatient/ambulatory, teleradiology, and hospital settings, while increasing recurring SaaS revenues.

  • Buyer
    UPS
    Target
    Andlauer Healthcare Group Inc. (AHG)
    Seller
    AHG shareholders (including Michael Andlauer and Andlauer Management Group, controlling shareholder)
    Location
    Canada
    Type
    Buyout

    UPS has completed its $1.6 billion acquisition of Andlauer Healthcare Group Inc. (AHG), a Canadian-headquartered healthcare logistics provider. Under the terms of the deal, AHG shareholders received CAD $55.00 per share in cash for a total purchase price of approximately CAD $2.2 billion.

  • Buyer
    DoseMe, Fairlong Capital
    Target
    Firstline
    Location
    British Columbia, Canada
    Type
    Buyout

    DoseMe, a portfolio company of Fairlong Capital, has acquired Firstline, a Vancouver-based clinical decision support platform. The acquisition combines Firstline's infectious disease guidance and antimicrobial stewardship capabilities with DoseMe's model-informed precision dosing software to create an end-to-end clinical decision support solution for hospitals and health systems.

  • Buyer
    Frontline Healthcare Partners
    Target
    Integracare Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    Frontline Healthcare Partners, a private equity firm focused on distributed healthcare businesses, has acquired a controlling interest in Integracare Inc., a private-pay home care provider headquartered in Toronto, Ontario. Frontline will partner with Integracare’s president and CEO Lee Grunberg to grow the business organically and via a dedicated acquisition strategy across Ontario and beyond.

  • Buyer
    123Dentist
    Target
    MCA Dental Group Limited
    Location
    Canada
    Type
    Addon

    123Dentist entered into a definitive agreement to acquire MCA Dental Group Limited, an Ottawa-based dental support organization with 27 locations across Ontario and Québec. After completion, MCA Dental Group’s corporate brand will be retired and operations will transition to 123Dentist under a unified brand.

  • Buyer
    PharmaCorp Rx Inc.
    Target
    Acquired Pharmacy (Western Canada)
    Location
    Canada
    Type
    Buyout

    PharmaCorp Rx Inc. (TSXV: PCRX) completed the purchase of a 100% interest in an independent pharmacy located in Western Canada for CAD 2,400,000, funded with cash on hand. The deal is the company's fourth completed pharmacy acquisition and is being executed in conjunction with its strategic alliance with PharmaChoice Canada to grow PharmaCorp's network of bannered community pharmacies.

  • Buyer
    Doximity, Inc.
    Target
    Pathway Medical Inc.
    Location
    Quebec, Canada
    Type
    Buyout

    Doximity has acquired Montreal-based Pathway Medical Inc., a startup specializing in AI-powered clinical reference and decision support. The deal closed July 29, 2025 for $26 million in cash plus up to $37 million in equity grants (total consideration up to $63 million), bringing Pathway's physician-led AI team and datasets into Doximity's clinical product suite.

  • Buyer
    WELL Health Technologies Corp.
    Target
    Personalized health / longevity clinic (Vancouver, British Columbia), Primary care and specialty clinic (Burnaby, British Columbia)
    Location
    British Columbia, Canada
    Type
    Buyout

    WELL Health Technologies Corp. completed two acquisitions of clinics in British Columbia on July 1, 2025 — a personalized/ longevity-focused clinic in Vancouver and a large primary care and specialty clinic in Burnaby. The acquisitions are expected to add over C$12 million in annual revenue and roughly C$3 million in Adjusted EBITDA, supporting WELL's continued expansion of its Canadian clinics platform.

  • Buyer
    VitalHub Corp.
    Target
    Novari Health Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    VitalHub Corp. has acquired Novari Health Inc., a Kingston-based provider of patient flow and referral management software, for total up-front consideration of $43.6 million plus potential performance-based consideration (up to $5.0 million earnout). The acquisition strengthens VitalHub's patient-flow and referral management capabilities and is expected to accelerate Novari's international expansion leveraging VitalHub's footprint, particularly in the UK.

  • Buyer
    MDBriefCase, Think Research
    Target
    Postcall
    Seller
    Eric Wu, Ziming Yang
    Location
    Ontario, Canada
    Type
    Buyout

    MDBriefCase, a Think Research subsidiary, has acquired Postcall, a fast-growing Canadian newsletter for physicians founded in 2023 by Eric Wu and Ziming Yang. The acquisition expands MDBriefCase's content offerings and audience reach across the medical community by adding Postcall's concise, weekly physician-focused newsletter.

  • Buyer
    HGGC, Snapdragon Capital Partners, Leonard Green & Partners
    Target
    Fullscript
    Location
    Ontario, Canada

    Fullscript, a healthcare platform powering whole-person care, announced an expanded investment from private equity firms HGGC and Snapdragon Capital Partners, supported by a continuation vehicle led by Leonard Green & Partners as sole lead investor. The financing provides liquidity options to existing investors while supplying capital to support Fullscript's next phase of growth and further development of its provider-facing platform and fulfillment capabilities.

  • Buyer
    TopGum Industries, Ltd.
    Target
    Island Abbey Nutritionals
    Location
    Prince Edward Island, Canada
    Type
    Buyout

    TopGum Industries, Ltd. completed its acquisition of Island Abbey Nutritionals, a Canadian CDMO specializing in supplement gummies and lozenges. The deal expands TopGum’s manufacturing and technological capabilities and is expected to push the combined revenue run-rate beyond USD 100 million.

  • Buyer
    Mable Health Inc., SeaFort Capital
    Target
    Anderson Orthopedics
    Seller
    Matthew Joss, Dan Mazur, Peter ten Krooden, Jacques Swanepoel, Jasmine Martin, Kelsey Nolin
    Location
    Manitoba, Canada
    Type
    Addon

    Mable Health, a national orthotics and prosthetics platform backed by SeaFort Capital, has acquired Winnipeg-based Anderson Orthopedics, expanding Mable's presence into Manitoba. Shareholders of Anderson Orthopedics will become shareholders of Mable Health and will continue operating clinics in Winnipeg and Brandon.

  • Buyer
    WELL Health Technologies Corp.
    Target
    HEALWELL AI Inc., Orion Health Holdings Limited
    Seller
    Dr. Sven Grail, Dr. George Christodoulou
    Location
    Ontario, Canada
    Type
    Addon

    WELL Health Technologies plans to amend and exercise its call right to acquire a majority controlling interest in HEALWELL AI (HEALWELL) concurrent with the anticipated closing of HEALWELL’s proposed acquisition of Orion Health on April 1, 2025. Following the exercise, WELL expects to begin consolidating HEALWELL from April 1, 2025 and to hold about 37% economic interest and about 69% voting interest in HEALWELL (non-diluted). Separately, HEALWELL completed the Orion Health acquisition on April 1, 2025 and WELL exercised the call right at the same time.

  • March 19, 2025
    Buyer
    Clario
    Target
    NeuroRx
    Location
    Quebec, Canada
    Type
    Buyout

    Clario has acquired NeuroRx, a Montreal-based imaging analysis provider specializing in neuroimaging for clinical trials, to strengthen Clario's neuroscience capabilities. NeuroRx founder Douglas Arnold will join Clario as Senior Scientific Advisor as the company integrates NeuroRx's imaging expertise to support drug development in CNS indications.

  • Buyer
    WELL Health Technologies Corp., CRH Medical Corporation
    Target
    Jack Nathan Health, Physicians For You, Harmony Anesthesia Staffing, Lonsdale Clinic, HealthPark (London, ON), Regional EMR (WELLSTAR acquisition), Healthcare technology services (WELLSTAR acquisition)
    Location
    Canada
    Type
    Buyout

    WELL Health Technologies completed seven acquisitions since December 2024 that together add approximately $100 million of annualized revenue, financed in cash. The deals include the acquisition of Jack Nathan Health (72-clinic network), physician recruitment platform Physicians For You, two primary care clinics (Lonsdale Clinic and HealthPark), two WELLSTAR technology assets (a regional EMR and a healthcare technology services business), and a 65% interest in Atlanta-based Harmony Anesthesia Staffing through its US subsidiary CRH.

  • Buyer
    Myant Corp.
    Target
    mmHg Inc.
    Location
    Alberta, Canada
    Type
    Buyout

    Myant Corp., a textile-computing and connected-health company based in Canada, has acquired mmHg Inc., a physician-led digital health firm specializing in remote blood pressure monitoring and cardiovascular risk management. The acquisition adds clinical-grade remote monitoring and cardiovascular analytics to Myant's offerings and expands Myant's market reach into the United States through mmHg's existing customer relationships and device partnerships.

  • Buyer
    Kensana Health Inc.
    Target
    ABcann Medicinals Inc., MediPharm Labs Napanee Facility
    Seller
    MediPharm Labs Corp.
    Location
    Ontario, Canada

    MediPharm Labs entered into a share purchase agreement to sell its Napanee, Ontario facility to Kensana Health for $5.5 million in cash. The deal will transfer all shares of MediPharm’s wholly owned subsidiary ABcann Medicinals Inc., including the Napanee Facility’s license and related building, land, and equipment.

  • Buyer
    Neuronetics, Inc.
    Target
    Greenbrook TMS Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    Greenbrook TMS Inc. has received final Ontario Superior Court approval for its plan of arrangement under which Neuronetics will acquire all issued and outstanding common shares of Greenbrook. The transaction is expected to close before the end of November 2024, subject to customary closing conditions.

  • Buyer
    Trive Capital, 808 Capital Partners
    Target
    Crunch Canada Holdings Inc.
    Location
    Ontario, Canada

    Trive Capital and 808 Capital Partners have invested in Crunch Canada Holdings Inc., the primary Crunch Fitness master franchisee in Canada headquartered in Cambridge, Ontario. The capital will support Crunch Canada’s club development and expansion plans across Ontario and Alberta and enable selective acquisitions to grow membership and footprint.

  • Buyer
    WELL Health Technologies Corp.
    Target
    Jack Nathan Medical Corp.
    Seller
    Jack Nathan Medical Corp.
    Location
    Ontario, Canada
    Type
    Buyout

    WELL Health Technologies Corp. completed the acquisition of the Canadian clinical assets of Jack Nathan Medical Corp., adding a portfolio of owned and licensed clinics (rebranded as WELL Health Medical Centres) and rights to operate clinics in Walmart Canada locations. The deal expands WELL’s national clinic footprint (72 clinics in total per WELL’s release), adds physician capacity, and is expected to drive immediate synergies and EBITDA-positive performance in 2025.

  • Buyer
    SNDL Inc.
    Target
    Indiva Limited (Indiva Group)
    Seller
    Indiva Group (selling entities under CCAA proceedings)
    Location
    Ontario, Canada
    Type
    Buyout

    SNDL Inc. has successfully closed the acquisition of Indiva Limited’s business and assets under Indiva’s CCAA proceedings. The deal includes Indiva’s 40,000-square-foot cannabis edibles production facility in London, Ontario, along with a portfolio of brands and SKUs intended to expand SNDL’s position in the infused edibles category.

  • Buyer
    VitalHub Corp.
    Target
    Strata Health Solutions Inc.
    Location
    Canada
    Type
    Buyout

    VitalHub Corp. has acquired Strata Health Solutions Inc., a Canada-based provider of patient flow and electronic referral software, for total up-front consideration of C$32.3 million plus potential performance-based consideration. The deal expands VitalHub’s healthcare software capabilities into the electronic referral and transitions-of-care market and adds Strata Health’s global customer footprint and recurring revenue base.

  • Buyer
    Move Health Holdings Corp.
    Target
    Fountain Wellness
    Location
    British Columbia, Canada
    Type
    Buyout

    Move Health Holdings Corp. has acquired Fountain Wellness, a multidisciplinary healthcare clinic and medical spa serving Delta and Surrey in the Lower Mainland of British Columbia. The acquisition brings med-spa and longevity services into Move Health’s portfolio and expands its in-person allied health and aesthetic service offering.

  • Buyer
    INTEGRAcare Inc.
    Target
    Living Assistance Services (Burlington & Oakville franchise)
    Seller
    Maureen Gillies (Franchise Owner)
    Location
    Ontario, Canada
    Type
    Buyout

    INTEGRAcare Inc., a Toronto-based private home healthcare provider, has acquired the Living Assistance Services franchise that operates in Burlington and Oakville, Ontario. The acquisition expands INTEGRAcare's geographic footprint in the Greater Toronto Area and brings additional in-home nursing and personal care services under its platform.

  • Buyer
    Aditxt, Inc.
    Target
    Appili Therapeutics Inc.
    Location
    Canada
    Type
    Buyout

    Aditxt, Inc. announced that Appili Therapeutics shareholders will vote on a proposed acquisition of all issued and outstanding shares of Appili through a plan of arrangement. Appili’s board recommended shareholders vote in favor, and Aditxt intends to use Appili’s infectious disease pipeline (including the FDA-approved LIKMEZ) to expand its reach in combating life-threatening infections and biodefense threats.

  • Buyer
    PharmaCorp Rx Inc.
    Target
    Acquired Pharmacy (Atlantic Canada)
    Location
    Canada
    Type
    Buyout

    PharmaCorp Rx Inc. (TSXV: PCRX) completed the acquisition of a 100% interest in a pharmacy business, including the associated land and buildings, located in Atlantic Canada for an aggregate purchase price of $15,377,013. The transaction was financed with $15,177,013 in cash and $200,000 in common shares and expands PharmaCorp’s roll-up of independent PharmaChoice Canada-affiliated pharmacies.

  • Buyer
    Better Choice Company Inc.
    Target
    SRx Health Solutions Inc.
    Seller
    Securityholders of SRx Health Solutions Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    Better Choice Company Inc. (NYSE American: BTTR) signed a definitive all-stock agreement to acquire SRx Health Solutions Inc. for approximately $125 million. The deal would combine Better Choice's pet health business (Halo) with SRx's Canadian specialty pharmacy network, creating a broader health and wellness company and unlocking operational synergies and geographic/vertical expansion.

  • Buyer
    North York LTD., BitcoinBlack
    Target
    Ask The Doctor
    Location
    Ontario, Canada
    Type
    Buyout

    North York LTD., the owner of the BitcoinBlack membership platform, has acquired Ask The Doctor, a telemedicine and virtual-care platform. The acquisition will integrate Ask The Doctor's private telemedicine services and cryptocurrency payment capability into BitcoinBlack's member benefits.

  • Buyer
    DAS Health Ventures, LLC (DAS Health)
    Target
    North American Digital Health division of an established Canadian digital transformation provider (unnamed)
    Location
    Canada
    Type
    Addon

    DAS Health Ventures (a Sheridan Capital Partners portfolio company) acquired the North American Digital Health division of an established Canadian digital transformation provider, giving DAS Health a footprint in Canada and expanding its senior care-focused health IT capabilities. The division adds managed IT, cybersecurity, cloud hosting, integrations, and revenue cycle management services to DAS Health's offerings as an add-on to its existing platform.

  • Buyer
    CPS Capital
    Target
    CloudMD Software & Services Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    CPS Capital, through an affiliate, completed a court-approved plan of arrangement to acquire all outstanding common shares of CloudMD Software & Services Inc., taking the company private for C$0.04 per share. The transaction will result in CloudMD being delisted from the TSX Venture Exchange as CPS Capital assumes ownership to pursue growth and operational objectives outside the public markets.

  • Buyer
    Quest Diagnostics
    Target
    LifeLabs
    Seller
    OMERS
    Location
    Ontario, Canada
    Type
    Buyout

    Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.

  • Buyer
    HEALWELL AI Inc.
    Target
    VeroSource Solutions Inc.
    Location
    New Brunswick, Canada
    Type
    Buyout

    HEALWELL AI Inc. has agreed to acquire VeroSource Solutions Inc. for total consideration of approximately $24.5 million in a two-step transaction (initial ~51% on July 1, 2024 and remaining ~49% expected about January 1, 2025), payable in cash, HEALWELL subordinate voting shares and a performance-based earn-out. VeroSource, a Canadian health-data interoperability and digital-front-door platform serving provincial health clients, is expected to generate over $8 million in 2024 with strong recurring revenue and margins and will expand HEALWELL's population-health and AI-driven capabilities.

  • Buyer
    Mable Health Inc., SeaFort Capital
    Target
    V2 Innovations Ltd.
    Seller
    Shareholders of V2 Innovations Ltd.
    Location
    Ontario, Canada
    Type
    Addon

    Mable Health Inc., a Halifax-based healthcare platform backed by SeaFort Capital, has acquired Kingston-based V2 Innovations Ltd., extending Mable Health's orthotics and prosthetics operations into Ontario. V2 shareholders will become shareholders of Mable Health and the V2 team will continue providing prosthetics, orthotics, assistive devices and related care from their existing locations as Mable builds a national healthcare platform.

  • Buyer
    Radformation, Inc.
    Target
    Limbus AI
    Location
    Saskatchewan, Canada
    Type
    Buyout

    Radformation, a provider of automation solutions for radiation therapy, has acquired Limbus AI, a Canada-headquartered developer of AI-driven automated contouring software for radiation therapy. The acquisition combines Radformation’s broad clinical treatment planning footprint with Limbus AI’s automated contouring technology to accelerate product innovation and expand AI capabilities in cancer care.

  • Buyer
    HEALWELL AI Inc.
    Target
    Intrahealth Systems Limited
    Seller
    WELL Health Technologies Corp.
    Location
    British Columbia, Canada
    Type
    Buyout

    HEALWELL AI Inc. agreed to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. for approximately $24.2 million, primarily paid in HEALWELL shares. The acquisition adds a mature, SaaS-based EHR platform supporting ~15,000 clinicians (expected >$12M revenue in 2024, >80% gross margins) and will be integrated with HEALWELL's AI tools to create an AI-powered EHR.

  • Buyer
    NeuPath Health Inc.
    Target
    SIBI Medical Inc. (operating as London Spine Institute)
    Seller
    SIBI Medical Inc.
    Location
    Ontario, Canada
    Type
    Buyout

    NeuPath Health Inc. (TSXV: NPTH) has closed the acquisition of the assets of SIBI Medical Inc., which operates as the London Spine Institute in London, Ontario. The asset purchase adds back, neck and spine specialists to NeuPath's clinic network, expanding its specialist capabilities and presence in the London, Ontario market.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Frequently Asked Questions

Who are the typical buyers in Canadian healthcare services deals?

Buyers include private‑equity firms, strategic healthcare platforms and digital health companies. Notable recent buyers are GTCR LLC, WELL Health Technologies Corp., SeaFort Capital, and specialist investors such as Frontline Healthcare Partners.

Which subsectors are attracting acquisitions?

Clinic and pharmacy roll‑ups, home‑care providers, orthotics/prosthetics platforms, and digital health capabilities (RWE/HEOR, clinical decision support, patient engagement and patient‑flow software) are active. Examples: dentalcorp Holdings Ltd., PharmaCorp Rx Inc., Integracare Inc., Novari Health Inc., and Mable Health Inc.

Where in Canada are most transactions taking place?

Recent deals are concentrated in Ontario and British Columbia, with additional activity reported in Quebec and Manitoba.

How are these transactions commonly structured?

Structures observed include strategic tuck‑ins and platform add‑ons, private‑equity take‑privates and minority rollovers or continuation financings. For example, GTCR LLC completed a take‑private of dentalcorp Holdings Ltd., and Fullscript received expanded private‑equity investment and a continuation vehicle.

Related Acquisition Pages